Advertisement
Asia
Subscribe to Asia

The Lead

Sartorius Selling Industrial Technologies Division to Minebea Co.

December 22, 2014 8:36 am | News | Comments

Sartorius, an international laboratory and pharmaceutical equipment provider, is selling its Industrial Technologies Division (Intec) to the Japanese Minebea Co., Ltd. (Minebea) and their partner, the Development Bank of Japan Inc.   

Charges Dropped Against Two Former Lilly Scientists

December 8, 2014 8:34 am | News | Comments

Two former Eli Lilly and Co. employees who were accused of sending trade secrets worth more than...

GlobalData: Age-Related Macular Degeneration Treatment Market Value to Exceed $10B by 2023

December 4, 2014 9:51 am | News | Comments

The Age-related Macular Degeneration treatment market across seven major countries (the US, UK,...

Otsuka to Buy Avanir for $3.5B

December 2, 2014 7:08 am | by By The Associated Press | News | Comments

Otsuka Pharmaceutical will spend $3.5 billion in cash to buy Avanir Pharmaceuticals in a deal...

View Sample

FREE Email Newsletter

Vetter Opens Singapore Office to Support Growing Asian Healthcare Market

November 20, 2014 8:42 am | News | Comments

Vetter has announced the opening of a new representative office in Singapore. The announcement was made at a ceremony attended by members of local government agencies and a number of executives of pharmaceutical/biotech companies with a presence in the Asian region, as well as Vetter executives.

China Convicts Pharmaceutical Web Marketer in Anti-Rumor Campaign

November 18, 2014 8:06 am | News | Comments

A Beijing court has convicted an Internet marketer of illegal business practices and sentenced him to four years in prison for posting false information and deleting posts critical of his clients, in a case that state media have used to praise a government crackdown on online expression.

Drug Maker Arrested in India Sterilization Deaths

November 17, 2014 8:25 am | by MUNEEZA NAQVI, Associated Press | News | Comments

Press Trust of India reported that Ramesh Mahawar of Mahawar Pharma Pvt Ltd and his son were arrested and charged with fraud. Police Superintendent O.P. Pal told PTI that the men were arrested on the complaint of food and drug administration officials.

Advertisement

India Doctor Arrested, Denies Role in Women Deaths, Blames Medication

November 13, 2014 10:07 am | by MUNEEZA NAQVI, Associated Press | News | Comments

The doctor who conducted sterilization procedures after which 13 women died in central India was arrested, but insisted he didn't do anything wrong — even though he said he used to perform up to 10 times more surgeries a day than allowed.    

Doctors Rush to India after Sterilization Deaths

November 12, 2014 8:30 am | by KATY DAIGLE, Associated Press | News | Comments

A team of doctors rushed to central India on Wednesday after at least 12 women died and dozens of others fell ill following sterilization surgeries in a free, nationwide program aimed at limiting births in the world's second-most populous nation, officials said.

China Factory Whirs Overtime to Make Ebola Suits

November 6, 2014 10:56 am | by ZHANG WEIQUN, Associated Press | News | Comments

Far from the Ebola hot zone, the sewing and gluing machines at a factory in China have been whirring more than usual to produce crucial yellow suits that protect the front-line medics more than 11,000 kilometers (7,000 miles) away in West Africa.

Beijing Wants APEC to Push Chinese Trade Pact

November 6, 2014 8:19 am | by JOE McDONALD, AP Business Writer | News | Comments

China plans to use a meeting of Asia-Pacific leaders to promote a regional trade initiative at a time when progress on a rival U.S.-led trade deal has stalled, injecting a note of rivalry into an annual summit that aims for consensus.   

GVK BIO to Acquire Vanta Bioscience

November 6, 2014 8:16 am | News | Comments

GVK BIO has announced the signing of a definitive agreement to acquire Vanta Bioscience, a full service preclinical GLP toxicology and safety assessment contract research organization operating out of Chennai, India.      

Advertisement

Ex-Union Carbide Chief Anderson Dies at 92

November 2, 2014 6:29 pm | by CURT ANDERSON, Associated Press | News | Comments

Warren M. Anderson, who headed Union Carbide Corp. when a chemical leak killed thousands of people in Bhopal, India, in 1984, has died in Florida at 92. Anderson's death was not announced by his family but was confirmed Friday by The Associated Press through public records.

New Bill in Japan Would Extend Sales Suspension of Quasi-Legal Drugs

November 2, 2014 5:28 pm | News | Comments

The ruling Liberal Democratic Party and its coalition partner have drawn up a draft amendment to the pharmaceutical affairs law that would extend the suspension of sales of quasi-legal drugs nationwide when a retailer is ordered to suspend sales of such drugs.

Chinese Pharma Firm to Establish Operations in Virginia

October 30, 2014 12:56 pm | News | Comments

Virginia's Gov. Terry McAuliffe said Thursday that UniTao Pharmaceuticals LLC has purchased the Boehringer Ingelheim plant that's slated to close by the end of the year.              

Catalent Appoints New Asia Pacific President

October 28, 2014 9:10 am | News | Comments

Catalent today announced the promotion of Australia Country General Manager, Mark Bisset, to President, Catalent Asia Pacific. He succeeds David Heyens who has announced that he plans to retire from Catalent on December 31st 2014.    

Fujifilm to Buy U.S. Vaccine Maker to Expand Biopharma Business

October 27, 2014 8:56 am | News | Comments

Fujifilm will acquire U.S. vaccine maker Kalon Biotherapeutics to expand its biopharmaceutical business, with the Japanese firm having gained prominence for offering a possible treatment for Ebola patients.        

Advertisement

China Gives $6M for Food in Ebola Countries

October 20, 2014 8:24 am | News | Comments

China has donated $6 million to help stave off food shortages in the three African countries worst affected by the Ebola virus, the World Food Program announced Monday, part of Beijing's growing assistance to a continent where its companies have become major investors.

Overseas Deal Rules End One Combo, Alter Another

October 3, 2014 1:46 pm | by Tom Murphy - AP Business Writer - Associated Press | News | Comments

New government rules aimed at curbing overseas deals that cut corporate taxes appear to be working, just not entirely the way regulators intended.                  

Chiltern Acquires Pacific Clinical Research

September 29, 2014 10:10 am | News | Comments

Chiltern has acquired Pacific Clinical Research, a pan-Asian CRO based in Singapore. The move allows Chiltern to offer integrated services throughout the Asia-Pacific region and strengthens in particular Chiltern's oncology and anti-infective offerings.

Analyst: GSK's $490M Fine to Spark Pharma Strategy Shift in Emerging Markets

September 24, 2014 11:21 am | News | Comments

The scandal and its repercussions will be felt deep into Big Pharma’s operations in emerging markets, causing a fundamental shift in product marketing approaches involving physicians.           

Limits on Overseas Mergers Prompt Renewed Debate

September 23, 2014 8:05 am | by JOSH LEDERMAN, Associated Press; JIM KUHNHENN, Associated Press | News | Comments

The Obama administration's decision to curb the ability of U.S. corporations to skirt taxes by merging with foreign companies kicked off an immediate election-season debate over when and how to tackle the nation's complex corporate tax code.  

China Fines GSK $492M for Bribery

September 19, 2014 5:47 am | by Joe Mcdonald - AP Business Writer - Associated Press | News | Comments

A former executive of drugmaker GlaxoSmithKline and four Chinese co-defendants have been sentenced to prison in a bribery case but may never have to serve that time. China's official Xinhua News Agency said Briton Mark Reilly and his Chinese co-defendants were given a three-year reprieve at their sentencing Friday.

Gilead to License Generic Version of Sovaldi

September 15, 2014 8:07 am | by The Associated Press | News | Comments

Gilead Sciences says it has reached a deal with several generic drugmakers to produce cheaper versions of its popular, expensive hepatitis C drug Sovaldi for use in developing countries.           

China's Premier Promises More Open Economy

September 10, 2014 8:09 am | by JOE McDONALD, AP Business Writer | News | Comments

China's premier promised Wednesday to open the world's No. 2 economy wider to foreign companies, promising favorable conditions despite a wave of anti-monopoly investigations that business groups say might be aimed at limiting competition.

Survey: Pharmaceutical and Other Foreign Companies in China Feel 'Targeted'

September 2, 2014 8:14 am | by JOE McDONALD, AP Business Writer | News | Comments

Foreign companies in China feel increasingly targeted for unfair enforcement of anti-monopoly and other laws and might cut investment if conditions fail to improve, a U.S. business group said Tuesday.         

Merck Serono Breaks Ground for New Pharmaceutical Manufacturing Facility in China

August 28, 2014 10:48 am | News | Comments

The new facility, which will be the group's second-largest pharmaceutical manufacturing facility worldwide, will focus on the bulk production and packaging of Glucophage®, Concor® and Euthyrox®, Merck Serono's leading brands for the treatment of diabetes, cardiovascular diseases and thyroid disorders, respectively.

Amerigen Pharmaceuticals and Ningbo Menovo Pharmaceutical to Collaborate on Generics

August 27, 2014 12:04 pm | News | Comments

Under the terms of the agreement, Amerigen and Menovo will jointly develop products for Amerigen to commercialize in the United States. Menovo will be responsible for manufacturing API and finished product whereas Amerigen will be responsible for clinical, regulatory and commercial activities in the United States.

Japan’s Scandal-Hit Stem-Cell Center to Be Downsized

August 27, 2014 9:08 am | Videos | Comments

One of Japan’s leading research institutions, the prestigious Riken Institute, will scale down the center at the heart of a stem-cell research scandal earlier this year.              

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading